- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medicamen Biotech Ltd (MEBI)
Medicamen Biotech Ltd stock price live, this page displays BO MEBI stock exchange data. View the MEBI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Medicamen Biotech Ltd real time stock price chart below.
What Is the Medicamen Biotech Ltd Stock Price Today?
The Medicamen Biotech Ltd stock price today is 355.95.
What Is the Stock Symbol for Medicamen Biotech Ltd?
The stock symbol for Medicamen Biotech Ltd is ""MEBI.""
What Stock Exchange Does Medicamen Biotech Ltd Trade On?
Medicamen Biotech Ltd is listed and trades on the BSE stock exchange.
Is Medicamen Biotech Ltd a Good Stock to Buy?
Determining whether Medicamen Biotech Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MEBI quote. (ISIN: INE646B01010)
What Is the Medicamen Biotech Ltd Stock Price Today?
The Medicamen Biotech Ltd stock price today is 355.95.
What Is the Stock Symbol for Medicamen Biotech Ltd?
The stock symbol for Medicamen Biotech Ltd is ""MEBI.""
What Stock Exchange Does Medicamen Biotech Ltd Trade On?
Medicamen Biotech Ltd is listed and trades on the BSE stock exchange.
Is Medicamen Biotech Ltd a Good Stock to Buy?
Determining whether Medicamen Biotech Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MEBI quote. (ISIN: INE646B01010)
355.95
-3.60(-1.00%)
Closed·
Fair Value
An estimate of a Medicamen Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
355.00
361.85
52 wk Range
355.00
630.00
MEBI Scorecard
Full Analysis
RSI suggests the stock is in oversold territory
Trading near 52-week Low
1/2
Fair Value
An estimate of a Medicamen Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
355.00361.85
52 wk Range
355.00630.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.28%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.28%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MEBI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Medicamen Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Medicamen Biotech Ltd Company Profile
Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarial, vitamins and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi, India.
Compare MEBI to Peers and Sector
Metrics to compare | MEBI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEBIPeersSector | |
|---|---|---|---|---|
P/E Ratio | 64.3x | 35.6x | −0.5x | |
PEG Ratio | −1.81 | 0.14 | 0.00 | |
Price/Book | 2.1x | 3.5x | 2.6x | |
Price / LTM Sales | 2.8x | 3.8x | 3.3x | |
Upside (Analyst Target) | - | 12.4% | 42.9% | |
Fair Value Upside | Unlock | 2.5% | 6.2% | Unlock |
Earnings
Latest Release
Jun 04, 2025
EPS / Forecast
2.27 / --
Revenue / Forecast
296.13M / --
People Also Watch
FAQ
What Stock Exchange Does Medicamen Biotech Trade On?
Medicamen Biotech is listed and trades on the Bombay Stock Exchange stock exchange.
What Is the Stock Symbol for Medicamen Biotech?
The stock symbol for Medicamen Biotech is "MEBI."
What Is the Medicamen Biotech Market Cap?
As of today, Medicamen Biotech market cap is 4.53B.
What Is Medicamen Biotech's Earnings Per Share (TTM)?
The Medicamen Biotech EPS (TTM) is 5.59.
When Is the Next Medicamen Biotech Earnings Date?
Medicamen Biotech will release its next earnings report on 06 Nov 2025.
From a Technical Analysis Perspective, Is MEBI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Medicamen Biotech Stock Split?
Medicamen Biotech has split 0 times.
How Many Employees Does Medicamen Biotech Have?
Medicamen Biotech has 378 employees.
What is the current trading status of Medicamen Biotech (MEBI)?
As of 12 Aug 2025, Medicamen Biotech (MEBI) is trading at a price of 355.95, with a previous close of 359.55. The stock has fluctuated within a day range of 355.00 to 361.85, while its 52-week range spans from 355.00 to 630.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.